Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04361214 Terminated - COVID-19 Clinical Trials

Leflunomide in Mild COVID-19 Patients

Start date: May 5, 2020
Phase: Phase 1
Study type: Interventional

This study aims to examine the tolerability of high dose of leflunomide in patients with COVID-19 who are being managed in the outpatient setting.

NCT ID: NCT04361123 Enrolling by invitation - COVID Clinical Trials

Atrium COVID-19 Syndromic and Serologic Surveillance

Start date: May 6, 2020
Phase:
Study type: Observational

The purpose of this research is to collect information about coronavirus exposures, symptoms, and health care visits due to the among Atrium Health clients and health care workers. Participation in this study will involve completing a daily questionnaire which covers participants coronavirus illness history or symptoms, health care seeking behaviors and treatments, contact with other sick people, and for health care workers, their use of personal protective equipment.

NCT ID: NCT04361032 Not yet recruiting - COVID19 Clinical Trials

Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia

TRONCHER
Start date: September 4, 2020
Phase: Phase 3
Study type: Interventional

Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, associated with standards treatments in COVID-19 (+) patients, Hospitalized In Intensive care in Tunisia. Multicentric, comparative, randomized study.

NCT ID: NCT04361019 Completed - Physical Activity Clinical Trials

Physical Activity in University Students Around COVID-19 Confinement

Start date: April 16, 2020
Phase:
Study type: Observational

The period of confinement due to COVID-19 may lead to reduced physical activity levels with negative consequences for health and quality of life in the short and long term, in case the sedentary habits are maintained over time. It is therefore essential to know the physical activity and health habits of university students during the confinement, as it could help in the design of effective strategies for the post-confinement period, as well as for any similar future situations. The general objective of the study is to know how university students have adapted their physical activity and health habits to the situation of confinement generated by COVID-19, as well as to identify the determining factors and the possible consequences. It is expected that there will be modifications in the patterns of physical activity in this situation, which could vary based on sociodemographic and economic determinants, and could affect parameters of health and quality of life. A survey will be sent to all students by email through the corresponding vice-rectorates of the sixteen participating universities (https://covid19.ehu.es/). The survey will be completed "online" anonymously. Among those participants who wish to keep participating in the study, a follow-up will be carried out one month and one year after the end of the confinement period. In this case, those subjects must indicate their willingness to keep participating and provide a contact email. The follow-up period will allow to know how physical activity and health habits are modified in the long term.

NCT ID: NCT04360980 Completed - COVID-19 Clinical Trials

The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection

Start date: March 20, 2020
Phase: Phase 2
Study type: Interventional

Based on data regarding the effect of colchicine on the modulation of immune system and decreasing cytokine release and inflammation the question arises whether colchicine, administered in a relatively low dose, could potentially have an effect on COVID-19 Polymerase chain reaction(PCR) positive patients .

NCT ID: NCT04360954 Completed - COVID Clinical Trials

Evaluation of Antibody Tests for COVID-19

Start date: April 23, 2020
Phase:
Study type: Observational

The purpose of this study is to evaluate the sensitivity and specificity of several marketed commercial or prototype test kits for antibody to SARS-CoV-2. The focus will be on rapid-format, point-of-care antibody test kits that detect both IgM and IgG antibodies to recombinant viral proteins. Note: No voluntary enrolment into this study will be conducted; all testing is to be conducted anonymously.

NCT ID: NCT04360876 Withdrawn - COVID-19 Clinical Trials

Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial

Start date: September 1, 2020
Phase: Phase 2
Study type: Interventional

This trial will determine the safety and estimate efficacy of targeted corticosteroids in mechanically ventilated patients with the hyper-inflammatory sub phenotype of ARDS due to coronavirus disease 2019 (COVID-19) by implementing a Phase 2A clinical trial.

NCT ID: NCT04360850 Completed - Online Therapy Clinical Trials

Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic

Start date: April 24, 2020
Phase:
Study type: Observational

A brief online survey to be completed by clinical therapists.

NCT ID: NCT04360837 Completed - COVID-19 Clinical Trials

PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients

Start date: May 6, 2020
Phase: N/A
Study type: Interventional

COVID-19 originated from Severe Acut Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection leads to critical condition due to hypoxemic respiratory failure with the background of viral pneumonia. Both alevolar recruitment and the subsequent optimal positive end-expiratory pressure (PEEP) adjustment has a pivotal role in the elimination of atelectasis developed by inflammation in the lung parenchyma The gold standard of the follow up of recruitment manoeuvre is the chest computed tomography (CT) examination. However, reduction of intrahospital transport and the exposure with healthcare workers are recommended because of the extremely virulent pathogen spreading easily by droplet infection. In this case bedside investigations have an utmost importance in the management of hygiene regulations. Electric impedance tomography (EIT) is a non-invasive, radiation free functional imaging technique easily applicable at the bedside.

NCT ID: NCT04360824 Completed - Clinical trials for COVID 19 Associated Coagulopathy

Covid-19 Associated Coagulopathy

Start date: May 6, 2020
Phase: Phase 4
Study type: Interventional

This prospective, randomized, open-label, multi-center interventional study is designed to compare the safety and efficacy of two LMWH dosing protocols in patients admitted to the University of Iowa Hospitals with COVID-19 who meet the modified ISTH Overt DIC criteria score ≥3. Patients will be randomized to standard prophylactic dose LMWH (standard of care arm) or intermediate-dose LMWH (intervention arm).